We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Draws Complete Response Letter for COPD Treatment
AstraZeneca Draws Complete Response Letter for COPD Treatment
The FDA has issued a complete response letter to AstraZeneca for its NDA for PT010 — a three drug combination product for treatment of chronic obstructive pulmonary disease (COPD).